Biblio Discovery — Demo Discovery Service

6 hasil untuk "Tim Grob"

Menampilkan 1–6 · 2,00 detik · RSS

  1. Artikel Jurnal

    Sex disparity in acute myeloid leukaemia with FLT3 internal tandem duplication mutations: implications for prognosis

    Monica Hellesøy; Caroline Engen; Tim Grob dkk.

    Molecular Oncology, Vol. 15 No. 9 · 2021 · Inggris · DOAJ Scopus

    Incidence, molecular presentation and outcome of acute myeloid leukaemia (AML) are influenced by sex, but little attention has been directed at untangling sex‐related molecular and phenotypic differences between female and male patients. While increased incidence and poor risk are generally…

  2. Artikel Jurnal

    FLT3‐ITD mutations in acute myeloid leukaemia – molecular characteristics, distribution and numerical variation

    Caroline Engen; Monica Hellesøy; Tim Grob dkk.

    Molecular Oncology, Vol. 15 No. 9 · 2021 · Inggris · DOAJ Scopus

    Recurrent somatic internal tandem duplications (ITD) in the FMS‐like tyrosine kinase 3 (FLT3) gene characterise approximately one third of patients with acute myeloid leukaemia (AML), and FLT3‐ITD mutation status guides risk‐adapted treatment strategies. The aim of this work was to characterise…

  3. Artikel Jurnal

    Advantages of a genomic DNA-based next-generation sequencing assay for detection of mutant NPM1 measurable residual disease in AML

    Christian M. Vonk; Tim Grob; Melissa Rijken dkk.

    Blood Advances, Vol. 9 No. 5 · 2025 · Inggris · DOAJ Scopus

    Abstract: Mutations in the nucleophosmin-1 (NPM1) gene are among the most common molecular aberrations in acute myeloid leukemia (AML). Various studies have established mutant NPM1 (mNPM1) as a faithful molecular measurable residual disease (MRD) marker with prognostic significance. Assessment of…

  4. Artikel Jurnal Teks lengkap

    Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome

    Tim Grob; Adil S. A. Al Hinai; Mathijs Arnoud Sanders dkk.

    Blood · 2022 · Inggris · OpenAlex Scopus

    Substantial heterogeneity within mutant TP53 acute myeloid leukemia (AML) and myelodysplastic syndrome with excess of blast (MDS-EB) precludes the exact assessment of prognostic impact for individual patients. We performed in-depth clinical and molecular analysis of mutant TP53 AML and MDS-EB to…